200 related articles for article (PubMed ID: 37026247)
1. Keratoprosthesis in dry eye disease.
Sharma S; Donthineni PR; Iyer G; Chodosh J; de la Paz MF; Maskati Q; Srinivasan B; Agarwal S; Basu S; Shanbhag SS
Indian J Ophthalmol; 2023 Apr; 71(4):1154-1166. PubMed ID: 37026247
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of the MICOF keratoprosthesis surgery.
Wang L; He X; Wang Q; Wu T; Liu A; Huang Y
Ocul Surf; 2021 Jul; 21():178-185. PubMed ID: 34118425
[TBL] [Abstract][Full Text] [Related]
3. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of MICOF keratoprosthesis in the end stage of autoimmune dry eyes: an experience in China.
Huang Y; Dong Y; Wang L; Du G; Yu J; Song J; Chiang HH
Br J Ophthalmol; 2012 Jan; 96(1):28-33. PubMed ID: 21454379
[TBL] [Abstract][Full Text] [Related]
5. [Clinical management of severe ocular surface disease].
Stoiber J; Grabner G
Klin Monbl Augenheilkd; 2005 Jul; 222(7):533-51. PubMed ID: 16034721
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency.
Shanbhag SS; Senthil S; Mohamed A; Basu S
Br J Ophthalmol; 2021 Apr; 105(4):473-478. PubMed ID: 32554443
[TBL] [Abstract][Full Text] [Related]
7. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
[TBL] [Abstract][Full Text] [Related]
8. Boston Keratoprosthesis Outcomes in Severe Ocular Chemical Burns in Southern China: A Retrospective Study.
Gu J; Zhai J; Zhou S; Chen J
Adv Ther; 2016 May; 33(5):760-73. PubMed ID: 27126407
[TBL] [Abstract][Full Text] [Related]
9. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
10. Infectious keratitis after Boston type 1 keratoprosthesis implantation.
Chan CC; Holland EJ
Cornea; 2012 Oct; 31(10):1128-34. PubMed ID: 22960647
[TBL] [Abstract][Full Text] [Related]
11. A review of corneal melting after Boston Keratoprosthesis.
Robert MC; Dohlman CH
Semin Ophthalmol; 2014; 29(5-6):349-57. PubMed ID: 25325860
[TBL] [Abstract][Full Text] [Related]
12. Boston type 1 based keratoprosthesis (Auro Kpro) and its modification (LVP Kpro) in chronic Stevens Johnson syndrome.
Basu S; Sureka S; Shukla R; Sangwan V
BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24663249
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Simultaneous penetrating keratoplasty with autologous simple limbal epithelial transplantation as an alternative to keratoprosthesis.
Sharma S; Singh S; Shanbhag SS
F1000Res; 2023; 12():488. PubMed ID: 37455854
[No Abstract] [Full Text] [Related]
14. Limbal stem cell transplantation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2008; 8(7):1-58. PubMed ID: 23074512
[TBL] [Abstract][Full Text] [Related]
15. Glaucoma associated with Boston type I keratoprosthesis.
Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
[TBL] [Abstract][Full Text] [Related]
16. The Boston Keratoprosthesis in severe ocular trauma.
Harissi-Dagher M; Dohlman CH
Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
[TBL] [Abstract][Full Text] [Related]
17. The Boston keratoprosthesis in Stevens-Johnson syndrome.
Sayegh RR; Ang LP; Foster CS; Dohlman CH
Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
[TBL] [Abstract][Full Text] [Related]
18. [Keratoprosthesis with Biological Haptic - The Düsseldorf-Offenburg-Experience with Osteo-Odonto- and Tibia-Keratoprosthesis].
Geerling G; Hille K
Klin Monbl Augenheilkd; 2017 Jun; 234(6):763-769. PubMed ID: 28586929
[TBL] [Abstract][Full Text] [Related]
19. Probing mechanisms and improving management of glaucoma following Boston keratoprosthesis surgery.
Geoffrion D; Koenekoop RK; Harissi-Dagher M
Acta Ophthalmol; 2023 Mar; 101(2):242-243. PubMed ID: 36794627
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
